xAnts

Breakthrough COVID-19 Treatment: JAK Inhibitors Show Promise as First-Line Therapy for Hospitalized Patients

Reuters

The fight against COVID-19 continues, and new research offers a beacon of hope. A groundbreaking study published in The Lancet Respiratory Medicine suggests that Janus kinase (JAK) inhibitors, a class of drugs known for their ability to modulate the ...undefined